AMD Research | Macular Degeneration Association

Brolocuziumab: Less frequent dosing/maintenance of robust visual gains in wet AMD

Jan 7, 2020 | age-related macular degeneration (ARMD), AMD Research, Wet macular degeneration

by: Lynda Charters This article was reviewed by Arshad M. Khanani, MD, MA; Joshua Mali, MD; and Patrick Mooney Brolucizumab (RTH258, Beovu, Novartis) received FDA approval for treatment of patients with wet age-related macular degeneration (AMD) during the last...

Dr. Mali’s top 5 stories in ophthalmology for 2019

Dec 17, 2019 | age-related macular degeneration (ARMD), AMD Research, Information, Latest News, macular degeneration, Macular Degeneration Treatment

By: Joshua Mali, MD It’s that time of the year again when I reflect on an exciting and dynamic year in ophthalmology! Here are my top 5 most significant stories in ophthalmology for 2019: 1. FDA approves brolucizumab for treatment of wet AMD As of this...

Stem cell treatment: What could possibly go wrong with procedure?

Dec 9, 2019 | age-related macular degeneration (ARMD), AMD Research, Information, Latest News, Stem cells

By: Lynda Charters Abstract / Synopsis: Stem cell therapies for ocular diseases often are of unproven efficacy and may result in vision loss, notes one surgeon. Reviewed by Thomas A. Albini, MD Stem cell technology is a rapidly growing, highly lucrative industry...

Clinic pitches unproven treatments to desperate patients, with tips on raising the cash

Dec 2, 2019 | age-related macular degeneration (ARMD), AMD Research, Information, Latest News, Macular Degeneration Treatment, Stem cells

Caution please beware clinics stating that they have a cure: The FDA has not approved most stem cell treatments and has said it considers many of them illegal. By William Wan and Laurie McGinley Dec. 1, 2019 at 8:41 p.m. EST By the time he called...

#Giving Tuesday 2019

Nov 27, 2019 | age-related macular degeneration (ARMD), AMD Research, Information, Latest News

First there was Black Friday followed by Cyber Monday. Tuesday is #GivingTuesday 2019 It will start at 8:00 am and continue through Wednesday @ 7:59 am #GivingTuesday is a global day of giving fueled by the power of social media and collaboration. Celebrated on the...

Yale-MIT-Harvard collaboration maps out cellular culprits of blindness

Nov 12, 2019 | age-related macular degeneration (ARMD), AMD Research, Gene Therapy, Information, Latest News

By: Kyoung A Lee According to statistics reported by Mayo Clinic, there are more than 200,000 new cases of macular degeneration in the United States each year. It is no secret that vision impairment is common among the elderly — age-related macular degeneration, or...